+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Zika Virus Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 158 Pages
  • May 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140550
The global market for Zika Virus Testing is estimated at US$212.8 Million in 2023 and is projected to reach US$314.5 Million by 2030, growing at a CAGR of 5.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Molecular Testing segment, which is expected to reach US$192.4 Million by 2030 with a CAGR of 6.3%. The Serological Testing segment is also set to grow at 4.9% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $56.5 Million in 2023, and China, forecasted to grow at an impressive 9.9% CAGR to reach $75.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Zika Virus Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Zika Virus Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Zika Virus Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Biocan Diagnostics, Chembio Diagnostic Systems, Inc., F. Hoffmann-La Roche AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 11 Featured):

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Zika Virus Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Zika Virus Testing Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Molecular Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Serological Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
JAPAN
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
CHINA
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: China Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 40: China 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
EUROPE
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 46: Europe 16-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
FRANCE
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 53: France Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 54: France Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 55: France 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
GERMANY
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 59: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 61: Germany 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 67: Italy 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 71: UK Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 72: UK Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 73: UK 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
SPAIN
  • Table 77: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 78: Spain Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 79: Spain 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 80: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
RUSSIA
  • Table 83: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 84: Russia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 85: Russia 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 86: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2024 & 2030
AUSTRALIA
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

Table Information